Beta Drugs IPO vs CMM Infraprojects IPO

Comparison between Beta Drugs IPO and CMM Infraprojects IPO.

IPO Details

Beta Drugs IPO is a SME Fixed Price IPO proposed to list at NSE SME while CMM Infraprojects IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Beta Drugs IPO is up to ₹18.41 Cr whereas the issue size of the CMM Infraprojects IPO is up to ₹17.27 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of CMM Infraprojects IPO is ₹40.00 per share.

 Beta Drugs IPOCMM Infraprojects IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹85.00 per share₹40.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size1600 shares3000 shares
Fresh Issue Size21,66,400 shares43,17,000 shares
Fresh Issue Size (Amount)up to ₹18.41 Crup to ₹17.27 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total21,66,400 shares43,17,000 shares
Issue Size Total (Amount)up to ₹18.41 Crup to ₹17.27 Cr

IPO Timetable

Beta Drugs IPO opens on Sep 29, 2017, while CMM Infraprojects IPO opens on Sep 29, 2017. The closing date of Beta Drugs IPO and CMM Infraprojects IPO is Oct 04, 2017, and Oct 04, 2017, respectively.

 Beta Drugs IPOCMM Infraprojects IPO
Issue OpenSep 29, 2017Sep 29, 2017
Issue CloseOct 04, 2017Oct 04, 2017
Basis Of Allotment (Tentative)Oct 10, 2017Oct 10, 2017
Listing date (Tentative)Oct 12, 2017Oct 12, 2017

Financials & KPIs

Beta Drugs IPO P/E ratio is , as compared to CMM Infraprojects IPO P/E ratio of .

 Beta Drugs IPOCMM Infraprojects IPO
Financials

Company Financials (Restated)

Period Ended31 Mar 201731 Mar 201631 Mar 2015
Assets24.5415.208.01
Total Income41.6826.390.26
Profit After Tax5.181.130.11
NET Worth7.382.201.07
Reserves and Surplus6.371.190.06
Total Borrowing7.527.754.37
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Mar 201731 Mar 201631 Mar 2015
Assets106.31102.9372.67
Total Income202.24178.77145.28
Profit After Tax6.242.291.93
NET Worth27.5921.3519.06
Reserves and Surplus24.8118.5616.28
Total Borrowing36.9332.8318.65
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)93.78%71.33%
Promoter Shareholding (Post-Issue)68.89%47.35%
Market Cap₹73.52 Cr.₹62.69 Cr.

Shares Offered

In the Beta Drugs IPO Retail Individual Investors (RII) are offered 10,83,200 shares while in CMM Infraprojects IPO retail investors are offered 10,83,200 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Beta Drugs IPO and 0 shares in CMM Infraprojects IPO.

 Beta Drugs IPOCMM Infraprojects IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation1,29,600 shares2,28,000 shares
QIB0 shares0 shares
NII10,83,200 shares21,57,000 shares
RII10,83,200 shares21,60,000 shares
Employee0 shares0 shares
Total21,66,400 shares43,17,000 shares

Bids Received (Subscription)

Beta Drugs IPO subscribed 18.97x in total, whereas CMM Infraprojects IPO subscribed 1.71x.

 Beta Drugs IPOCMM Infraprojects IPO
NII (times)29.93x1.68x
RII (times)8.00x1.74x
Total (times)18.97x1.71x

Compare with others

Compare:

Beta Drugs IPO Vs CMM Infraprojects IPO